Skip to Main Content

Author Details

Amy C Degnim
Mayo Clinic
1996
213
44
PMIDPaper TitleJournal TitlePublished Year
38091020Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era.JAMA Surg2024
37863697Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer.Surgery2024
37872454Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.Ann Surg Oncol2024
36380012Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers.Breast Cancer Res Treat2023
37615191Lessons learned from the COVID-19 pandemic: Using telemedicine for pre-operative surgical evaluation in breast disease.J Telemed Telecare2023
37870954Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial.JAMA Surg2023
37492279Patient Experience and Clinical Outcomes after Same-day Outpatient Mastectomy and Immediate Breast Reconstruction Protocol during the Global Pandemic.Plast Reconstr Surg Glob Open2023
35656869The Benefits of Local Anesthesia Used in Mastectomy Without Reconstruction.Am Surg2023
37251618Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data.Clin Transl Radiat Oncol2023
37223927Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast.Clin Cancer Res2023
36596665Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.Cancer Prev Res (Phila)2023
34920159Paraneoplastic myelopathy with amphiphysin autoantibodies and lobular breast carcinoma in situ.J Neurol Sci2022
35773563Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.Ann Surg Oncol2022
35503494Serum hormone levels and normal breast histology among premenopausal women.Breast Cancer Res Treat2022
35366464The breast tissue microbiome, stroma, immune cells and breast cancer.Neoplasia2022
35854027Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes.Ann Surg Oncol2022
35821041Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence.Breast Cancer Res2022
35385996Sexual Well-Being After Nipple-Sparing Mastectomy: Does Preservation of the Nipple Matter?Ann Surg Oncol2022
36109410ASO Visual Abstract: Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes.Ann Surg Oncol2022
35923341Radiation-associated angiosarcoma of the breast with initial presentation as non-mass enhancement on MRI.Radiol Case Rep2022
36114500Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics.BMC Med Genomics2022
35046392Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning.NPJ Breast Cancer2022
32861439Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ.Surgery2021
33674749Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.Oncogene2021
33811165Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk-Letter.Cancer Epidemiol Biomarkers Prev2021
34651376Primary tumor resection in patients with stage IV breast cancer: 10-year experience.Breast J2021
34275042Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy.Ann Surg Oncol2021
34261476Somatic mutations in benign breast disease tissues and association with breast cancer risk.BMC Med Genomics2021
33097489Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake.Cancer Prev Res (Phila)2021
31633546Single-Stage Direct-to-Implant Breast Reconstruction: A Comparison Between Subpectoral Versus Prepectoral Implant Placement.Ann Plast Surg2020
31757875Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine.Clin Cancer Res2020
31933142Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease.Breast Cancer Res Treat2020
31985613Prepectoral Two-Stage Implant-Based Breast Reconstruction with and without Acellular Dermal Matrix: Do We See a Difference?Plast Reconstr Surg2020
32069138Bioimpedance Spectroscopy of the Breast.Lymphat Res Biol2020
32718942Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy.Cancer Prev Res (Phila)2020
32623609Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery.Ann Surg Oncol2020
33019355Using operative features to identify surgical complexity: a case in breast surgery practice.Annu Int Conf IEEE Eng Med Biol Soc2020
32840744Breast Reconstruction in the Setting of Stage 4 Breast Cancer: Is It Worthwhile?Ann Surg Oncol2020
32812177Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial.Breast Cancer Res Treat2020
30996252Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation.Mod Pathol2019
31764629Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years.Plast Reconstr Surg2019
31416221Two-Staged Implant-Based Breast Reconstruction: A Long-Term Outcome Study in a Young Population.Medicina (Kaunas)2019
31342370Outcomes of >â¿¿1300 Nipple-Sparing Mastectomies with Immediate Reconstruction: The Impact of Expanding Indications on Complications.Ann Surg Oncol2019
31395398Mastectomy and immediate breast reconstruction in the elderly: Trends and outcomes.Surgery2019
31477010Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples.BMC Genomics2019
31044105Surgical Outcomes of Prepectoral Versus Subpectoral Implant-based Breast Reconstruction in Young Women.Plast Reconstr Surg Glob Open2019
30850011Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study.Breast Cancer Res2019
28903167Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.JAMA Surg2018
30029048Cellular fibroepithelial lesions of the breast: A long term follow up study.Ann Diagn Pathol2018
29968026Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely<sup>®</sup> Campaign.Ann Surg Oncol2018
  • 1 - 50 of 213

Recommended Authors

Suliat Nurudeen
University of Maryland School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Simona F Shaitelman
University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Shayna L Showalter
University of Virginia School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Marcia E Bouton
Maricopa Medical Center
Career Start Year 2007
Number of shared co-authors 0
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Carolien H M van Deurzen
Erasmus MC Cancer Institute
Career Start Year 2004
Number of shared co-authors 13
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 0
Willem Vreuls
Canisius Wilhelmina Hospital
Career Start Year 2000
Number of shared co-authors 3
Oscar M Rueda
University of Cambridge
Career Start Year 2000
Number of shared co-authors 0
Rita A Sakr
Universite Libre de Bruxelles
Career Start Year 2000
Number of shared co-authors 3
Ian K Komenaka
Ironwood Cancer and Research Centers, AZ Arizona Cancer Center, University of Arizona
Career Start Year 1999
Number of shared co-authors 5
Isabel T Rubio
Clinica Universidad de Navarra, Cancer Center Universidad de Navarra
Career Start Year 1998
Number of shared co-authors 2
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 4
Sarah L Blair
University of California
Career Start Year 1996
Number of shared co-authors 3
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Elizabeth L Salisbury
Prince of Wales Hospital
Career Start Year 1995
Number of shared co-authors 0
Peter Bult
Radboud University Medical Center
Career Start Year 1994
Number of shared co-authors 3
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 4
Wey L Leong
University Health Network
Career Start Year 1992
Number of shared co-authors 1
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 3
Richard J Barth
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 0
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 3
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year 1987
Number of shared co-authors 0
Elizabeth Mallon
Queen Elizabeth University Hospital
Career Start Year 1986
Number of shared co-authors 0
Craig D Shriver
Walter Reed National Military Medical Center
Career Start Year 1985
Number of shared co-authors 1
Bruce Youngson
University Health Network
Career Start Year 1985
Number of shared co-authors 1
David R McCready
University of Toronto, University Health Network
Career Start Year 1984
Number of shared co-authors 3
Sunil R Lakhani
University of Queensland
Career Start Year 1983
Number of shared co-authors 14
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 12

Collaborators

Judy C Boughey
Mayo Clinic
Co-authored papers 86
Tanya L Hoskin
Division of Biostatistics and Clinical Trials, Mayo Clinic
Co-authored papers 74
Marlene H Frost
Mayo Clinic
Co-authored papers 52
Stacey J Winham
Mayo Clinic
Co-authored papers 28
Mark E Sherman
Mayo Clinic
Co-authored papers 16
Kathleen R Brandt
Mayo Clinic
Co-authored papers 11
Clive S Grant
Inova Health System
Co-authored papers 10
James N Ingle
Mayo Clinic
Co-authored papers 9
Elizabeth B Habermann
Department of Health Services Research, Mayo Clinic
Co-authored papers 7
Sandhya Pruthi
Mayo Clinic
Co-authored papers 7
Matthew P Goetz
Mayo Clinic
Co-authored papers 6
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 5
Gary L Keeney
Mayo Clinic
Co-authored papers 4
Lee J Melton
Mayo Clinic
Co-authored papers 3
Richard J Santen
Co-authored papers 3
Brent A Bauer
Mayo Clinic
Co-authored papers 3
Vera J Suman
Mayo Clinic
Co-authored papers 3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Anna Maria Storniolo
Co-authored papers 3
Ruth M Pfeiffer
National Cancer Institute.
Co-authored papers 3
Jeroen A W M van der Laak
Radboud University Medical Center
Co-authored papers 3
Louise A Brinton
National Cancer Institute
Co-authored papers 3
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 3
Kathryn J Ruddy
Mayo Clinic
Co-authored papers 2
Daniel J Schaid
Mayo Clinic
Co-authored papers 2
Christopher G Scott
Mayo Clinic
Co-authored papers 2
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Fergus J Couch
Mayo Clinic
Co-authored papers 2
Ann M Farrell
Mayo Clinic Libraries
Co-authored papers 2
Ivy A Petersen
Mayo Clinic
Co-authored papers 2
Release 1.2